STERIS Revenue 2010-2025 | STE

STERIS revenue for the twelve months ending March 31, 2025 was $5.460B, a 6.24% increase year-over-year.

  • STERIS annual revenue for 2025 was $5.46B, a 6.24% increase from 2024.
  • STERIS annual revenue for 2024 was $5.139B, a 13.28% increase from 2023.
  • STERIS annual revenue for 2023 was $4.536B, a 7.41% increase from 2022.

STERIS Revenue 2010-2025 | STE

  • STERIS annual revenue for 2025 was $5.46B, a 6.24% increase from 2024.
  • STERIS annual revenue for 2024 was $5.139B, a 13.28% increase from 2023.
  • STERIS annual revenue for 2023 was $4.536B, a 7.41% increase from 2022.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$185B
Thermo Fisher Scientific (TMO)$152.9B
Edwards Lifesciences (EW)$44.9B
Alcon (ALC)$43B
IDEXX Laboratories (IDXX)$41.9B
DexCom (DXCM)$32.9B
IQVIA Holdings (IQV)$27.5B
Mettler-Toledo (MTD)$24.2B
SONOVA HOLDING (SONVY)$17.2B
Waters (WAT)$16.8B
Hologic (HOLX)$14.2B
Sysmex ADR (SSMXY)$10.5B
Penumbra (PEN)$8.9B
Masimo (MASI)$8.4B
Globus Medical (GMED)$7B
Glaukos (GKOS)$5.5B
Teleflex (TFX)$4.9B
Integer Holdings (ITGR)$3.9B
TransMedics (TMDX)$3.5B
PROCEPT BioRobotics (PRCT)$3.2B
LivaNova (LIVN)$2.3B
Nihon Kohden (NHNKY)$2.2B
Elekta AB (EKTAY)$1.9B
Veracyte (VCYT)$1.8B
Alphatec Holdings (ATEC)$1.5B
Artivion (AORT)$1.3B
OPKO Health (OPK)$1.1B
Paragon 28 (FNA)$1.1B
Pulse Biosciences (PLSE)$1B
Tandem Diabetes Care (TNDM)$974M